CytoSolve
A BREAKTHROUGH PLATFORM FOR MATHEMATICALLY MODELING THE WHOLE CELL AND COMPLEX MOLECULAR PATHWAYS

Problems In Drug Development

The trillion dollar pharmaceutical industry is in peril where current drug development pipeline is slow and inefficient and incapable of being extended to multi-combination drug therapies. It takes too long (12-16 years), costs too much ($5 billion per drug), and only 20% entering Phase 1 clinical trials are successful. The current drug development process is archaic, wet lab centric, relying on in vitro and in vivo, in both animals and humans, and not information centric, and unable to integrate and reuse existing scientific data and knowledge.

The CytoSolve® Solution

Based on proprietary in silico technology and a feedback systems design that reuses scientific data from wet lab and clinical trials, CytoSolve offers a revolutionary and proven information-centric platform that enables accurate quantitative mechanistic models, for predicting complex molecular phenomena, for the rapid testing and development of single and multi-combination compounds for drug, nutritional supplement, and medical foods, by minimizing the need for in vitro and in vivo testing.

Integrating Published Scientific Research from Global Institutions

 
CytoSolve Research Update - Building Pathways to Wisdom
CytoSolve team has reviewed the results of 186,878 experiments across 3596 institutions by 9460 scientists.
Last updated on: June. 29, 2015
Careers at CytoSolve
Qualified candidates required for the position of Systems Biologist. For more details, click here.